You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

419 Results
Document
Jan 2021
Document
Feb 2021
Document
Feb 2021
Regimen
Cancer Type:
Hematologic, 
Myeloproliferative Neoplasms (MPNs)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    fedratinib - For the treatment of splenomegaly and/or disease related symptoms of myelofibrosis according to clinical criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
fedratinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2025
Document
Apr 2021
Document
May 2021
Document
May 2021
Guidelines and Advice
Status: Current
ID: GL 2-30B
May 2021
Document
Jun 2021
Guidelines and Advice
Status: Current
Version: 3.1
Oct 2024

Pages